2024 Q2 Form 10-Q Financial Statement

#000090831124000019 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $34.44M $34.00M
YoY Change 5.13% 17.59%
Cost Of Revenue $18.91M $19.54M
YoY Change -1.5% 14.41%
Gross Profit $15.53M $14.46M
YoY Change 14.49% 22.18%
Gross Profit Margin 45.1% 42.52%
Selling, General & Admin $1.538M $2.309M
YoY Change -8.67% -56.31%
% of Gross Profit 9.9% 15.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.544M $6.567M
YoY Change -68.0% -31.62%
% of Gross Profit 42.13% 45.43%
Operating Expenses $7.994M $8.787M
YoY Change -63.92% -40.58%
Operating Profit $7.539M $5.668M
YoY Change -187.78% -291.75%
Interest Expense $9.226M $8.977M
YoY Change 5.94% 43.95%
% of Operating Profit 122.38% 158.38%
Other Income/Expense, Net
YoY Change
Pretax Income -$564.0K -$3.635M
YoY Change -96.9% -50.34%
Income Tax $288.0K $270.0K
% Of Pretax Income
Net Earnings -$796.0K -$3.730M
YoY Change -95.41% -46.34%
Net Earnings / Revenue -2.31% -10.97%
Basic Earnings Per Share -$0.43 -$0.54
Diluted Earnings Per Share -$0.43 -$0.54
COMMON SHARES
Basic Shares Outstanding 22.79M shares 22.79M shares
Diluted Shares Outstanding 22.74M shares 22.74M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.32M $21.31M
YoY Change 19.39% -5.26%
Cash & Equivalents $29.32M $21.31M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $5.731M $6.030M
Other Receivables $0.00 $0.00
Total Short-Term Assets $35.05M $27.34M
YoY Change 19.91% -10.29%
LONG-TERM ASSETS
Property, Plant & Equipment $699.3M $700.6M
YoY Change -1.76% -2.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $34.50M $33.71M
YoY Change 25.35% 18.8%
Other Assets $49.52M $52.13M
YoY Change -12.45% -10.49%
Total Long-Term Assets $856.2M $860.2M
YoY Change -3.85% -7.22%
TOTAL ASSETS
Total Short-Term Assets $35.05M $27.34M
Total Long-Term Assets $856.2M $860.2M
Total Assets $891.2M $887.5M
YoY Change -3.1% -7.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.82M $25.64M
YoY Change -14.82% -18.46%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.72M $28.97M
YoY Change -9.63% -17.98%
LONG-TERM LIABILITIES
Long-Term Debt $485.1M $472.8M
YoY Change -0.55% -9.21%
Other Long-Term Liabilities $11.94M $13.64M
YoY Change -16.9% -14.6%
Total Long-Term Liabilities $497.1M $486.5M
YoY Change -1.02% -9.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.72M $28.97M
Total Long-Term Liabilities $497.1M $486.5M
Total Liabilities $529.8M $515.4M
YoY Change -1.6% -9.9%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $23.00K $23.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $351.1M $369.9M
YoY Change
Total Liabilities & Shareholders Equity $891.2M $887.5M
YoY Change -3.1% -7.32%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$796.0K -$3.730M
YoY Change -95.41% -46.34%
Depreciation, Depletion And Amortization $6.544M $6.567M
YoY Change -68.0% -31.62%
Cash From Operating Activities $3.924M $1.616M
YoY Change -41.03% -41.58%
INVESTING ACTIVITIES
Capital Expenditures $2.092M $1.690M
YoY Change 27.64% -98.34%
Acquisitions
YoY Change
Other Investing Activities $1.097M $1.297M
YoY Change -92.7% -87.62%
Cash From Investing Activities -$995.0K -$393.0K
YoY Change -107.44% -99.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.269M $191.0K
YoY Change -112.25% -99.75%
NET CHANGE
Cash From Operating Activities 3.924M $1.616M
Cash From Investing Activities -995.0K -$393.0K
Cash From Financing Activities 2.269M $191.0K
Net Change In Cash 5.198M $1.414M
YoY Change 244.01% -113.28%
FREE CASH FLOW
Cash From Operating Activities $3.924M $1.616M
Capital Expenditures $2.092M $1.690M
Free Cash Flow $1.832M -$74.00K
YoY Change -63.47% -99.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/srt/2023#HotelMember
CY2024Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/srt/2023#HotelMember
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22786741 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22786741 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
23000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
23000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
851234000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
852476000 usd
CY2024Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
936151000 usd
CY2023Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
921925000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
369888000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
374403000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
2191000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
2366000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372079000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
376769000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
887503000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
891200000 usd
CY2024Q1 cmct Operating Lease And Other Property Revenue
OperatingLeaseAndOtherPropertyRevenue
18773000 usd
CY2023Q1 cmct Operating Lease And Other Property Revenue
OperatingLeaseAndOtherPropertyRevenue
14886000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11264000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10923000 usd
CY2024Q1 cmct Interest And Other Operating Income
InterestAndOtherOperatingIncome
3961000 usd
CY2023Q1 cmct Interest And Other Operating Income
InterestAndOtherOperatingIncome
3103000 usd
CY2024Q1 us-gaap Revenues
Revenues
33998000 usd
CY2023Q1 us-gaap Revenues
Revenues
28912000 usd
CY2024Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
17981000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
15225000 usd
CY2024Q1 cmct Related Party Asset Management Fees And Other Fees
RelatedPartyAssetManagementFeesAndOtherFees
394000 usd
CY2023Q1 cmct Related Party Asset Management Fees And Other Fees
RelatedPartyAssetManagementFeesAndOtherFees
720000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
8977000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
6236000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1619000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1925000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
690000 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3360000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6478000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9502000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
37307000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
38104000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-326000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
768000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1104000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3635000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7320000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
270000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
256000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3905000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-7576000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-175000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-625000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3730000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6951000 usd
CY2024Q1 cmct Redeemable Preferred Stock Dividends Declared And Accumulated
RedeemablePreferredStockDividendsDeclaredAndAccumulated
7759000 usd
CY2023Q1 cmct Redeemable Preferred Stock Dividends Declared And Accumulated
RedeemablePreferredStockDividendsDeclaredAndAccumulated
5391000 usd
CY2024Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
806000 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
373000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12295000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12715000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22738000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22707000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22738000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22707000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
376769000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.085
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1937000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3905000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372079000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362033000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
5002000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.085
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1933000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-7576000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
378682000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3905000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-7576000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6567000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9604000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1104000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
624000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
395000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-14000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-1000 usd
CY2024Q1 cmct Unrealized Premium Adjustment
UnrealizedPremiumAdjustment
196000 usd
CY2023Q1 cmct Unrealized Premium Adjustment
UnrealizedPremiumAdjustment
265000 usd
CY2024Q1 cmct Amortization And Accretion On Loans Receivable Net
AmortizationAndAccretionOnLoansReceivableNet
8000 usd
CY2023Q1 cmct Amortization And Accretion On Loans Receivable Net
AmortizationAndAccretionOnLoansReceivableNet
99000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
411000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
55000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-339000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
55000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
55000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-326000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
768000 usd
CY2024Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
5799000 usd
CY2023Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
7849000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
5471000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
6271000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
560000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Loans Held For Sale
ProceedsFromCollectionOfLoansHeldForSale
605000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-160000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-150000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1130000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4163000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
793000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5424000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-986000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14007000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
285000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
246000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
658000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2119000 usd
CY2024Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-130000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
722000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1616000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2766000 usd
CY2024Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
1690000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
4816000 usd
CY2024Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
96731000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
1096000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
16714000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
530000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
6626000 usd
CY2024Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
1934000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
2932000 usd
CY2024Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
2665000 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
3323000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-393000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91068000 usd
CY2024Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3615000 usd
CY2023Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
108203000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
5000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
212000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
54141000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
560000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
607000 usd
CY2024Q1 cmct Payments Of Deferred Stock Issuance Costs
PaymentsOfDeferredStockIssuanceCosts
372000 usd
CY2023Q1 cmct Payments Of Deferred Stock Issuance Costs
PaymentsOfDeferredStockIssuanceCosts
283000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2400000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1937000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1933000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
19549000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
23644000 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
7651000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9820000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
10223000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
88884000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
191000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77655000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1414000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10647000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44228000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57480000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45642000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46833000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21307000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22491000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
24335000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
24342000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45642000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46833000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
8636000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4093000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
16000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1514000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3494000 usd
CY2024Q1 cmct Proceeds From The Sale Of Real Estate Committed But Not Yet Paid
ProceedsFromTheSaleOfRealEstateCommittedButNotYetPaid
0 usd
CY2023Q1 cmct Proceeds From The Sale Of Real Estate Committed But Not Yet Paid
ProceedsFromTheSaleOfRealEstateCommittedButNotYetPaid
17657000 usd
CY2024Q1 cmct Other Amounts Due From Unconsolidated Joint Venture Partners Included In Other Assets
OtherAmountsDueFromUnconsolidatedJointVenturePartnersIncludedInOtherAssets
1445000 usd
CY2023Q1 cmct Other Amounts Due From Unconsolidated Joint Venture Partners Included In Other Assets
OtherAmountsDueFromUnconsolidatedJointVenturePartnersIncludedInOtherAssets
1445000 usd
CY2024Q1 cmct Non Cash Contributions To Unconsolidated Joint Venture
NonCashContributionsToUnconsolidatedJointVenture
0 usd
CY2023Q1 cmct Non Cash Contributions To Unconsolidated Joint Venture
NonCashContributionsToUnconsolidatedJointVenture
8600000 usd
CY2024Q1 cmct Stock Offering Costs Not Yet Paid
StockOfferingCostsNotYetPaid
247000 usd
CY2023Q1 cmct Stock Offering Costs Not Yet Paid
StockOfferingCostsNotYetPaid
101000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1937000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1933000 usd
CY2024Q1 cmct Accrual Of Dividends Payable To Preferred Stockholders
AccrualOfDividendsPayableToPreferredStockholders
2610000 usd
CY2023Q1 cmct Accrual Of Dividends Payable To Preferred Stockholders
AccrualOfDividendsPayableToPreferredStockholders
1832000 usd
CY2024Q1 cmct Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity
OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity
513000 usd
CY2023Q1 cmct Offering Costs Offset Against Redeemable Preferred Stock Temporary Equity
OfferingCostsOffsetAgainstRedeemablePreferredStockTemporaryEquity
403000 usd
CY2024Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
0 usd
CY2023Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
8812000 usd
CY2024Q1 us-gaap Notes Assumed1
NotesAssumed1
0 usd
CY2023Q1 us-gaap Notes Assumed1
NotesAssumed1
181318000 usd
CY2024Q1 cmct Redeemable Preferred Stock Fees Incurred But Not Yet Paid
RedeemablePreferredStockFeesIncurredButNotYetPaid
246000 usd
CY2023Q1 cmct Redeemable Preferred Stock Fees Incurred But Not Yet Paid
RedeemablePreferredStockFeesIncurredButNotYetPaid
413000 usd
CY2024Q1 cmct Noncash Financing And Investing Activities Acquisition To Noncontrolling Interests
NoncashFinancingAndInvestingActivitiesAcquisitionToNoncontrollingInterests
0 usd
CY2023Q1 cmct Noncash Financing And Investing Activities Acquisition To Noncontrolling Interests
NoncashFinancingAndInvestingActivitiesAcquisitionToNoncontrollingInterests
5002000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:8pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. ORGANIZATION AND OPERATIONS</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Creative Media &amp; Community Trust Corporation (formerly known as CIM Commercial Trust Corporation) (the “Company”), is a Maryland corporation and real estate investment trust (“REIT”). The Company primarily acquires, develops, owns and operates both premier multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to its multifamily investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also owns one hotel in northern California and a lending platform that originates loans under the Small Business Administration (“SBA”) 7(a) loan program. The Company seeks to apply the expertise of CIM Group Management, LLC (“CIM Group”) and its affiliates to the acquisition, development and operation of premier multifamily properties and creative office assets that cater to rapidly growing industries such as technology, media and entertainment in vibrant and emerging communities throughout the United States.</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s common stock, $0.001 par value per share (“Common Stock”), is currently traded on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CMCT”, and on the Tel Aviv Stock Exchange (the “TASE”) under the ticker symbol “CMCT.” The Company has authorized for issuance 900,000,000 shares of common stock and 100,000,000 shares of preferred stock (“Preferred Stock”).</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2022, the Company conducted a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> public offering with respect to shares of its Series A1 Preferred Stock, par value $0.001 per share with an initial stated value of $25.00 per share, subject to adjustment (Note 11). The Company has filed a Registration Statement on Form S-11 in respect of such offering and anticipates continuing the offering upon effectiveness of such Registration Statement on Form S-11. Nothing contained in this Quarterly Report on Form 10-Q is or shall be deemed to be an offer to sell any securities of the Company, or the solicitation of any offer to buy any securities of</span></div>the Company, in any jurisdiction, which may only be made pursuant to appropriate offering documentation.
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2024Q1 cmct Preferred Stock Including Temporary Equity Shares Authorized
PreferredStockIncludingTemporaryEquitySharesAuthorized
100000000 shares
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interim Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The accompanying interim consolidated financial statements of the Company have been prepared by the Company’s management in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Certain information and note disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the interim consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The accompanying financial information reflects all adjustments which are, in the opinion of the Company’s management, of a normal recurring nature and necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. The accompanying interim consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto, included in the 2023 Form 10-K.</span></div>
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q1 us-gaap Incentive To Lessee
IncentiveToLessee
3900000 usd
CY2023Q4 us-gaap Incentive To Lessee
IncentiveToLessee
3900000 usd
CY2024Q1 cmct Incentive To Lessee Accumulated Amortization
IncentiveToLesseeAccumulatedAmortization
3400000 usd
CY2023Q4 cmct Incentive To Lessee Accumulated Amortization
IncentiveToLesseeAccumulatedAmortization
3300000 usd
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
16348000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
12474000 usd
CY2024Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2425000 usd
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2412000 usd
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
18773000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
14886000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
868000 usd
CY2024Q1 cmct Tenant Reimbursements Excluding Lease Agreements
TenantReimbursementsExcludingLeaseAgreements
0 usd
CY2023Q1 cmct Tenant Reimbursements Excluding Lease Agreements
TenantReimbursementsExcludingLeaseAgreements
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2024Q1 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
-8300000 usd
CY2023Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
-8400000 usd
CY2024Q1 cmct Loan And Leases Receivable Nonaccrual Loan And Lease Status Past Due Period
LoanAndLeasesReceivableNonaccrualLoanAndLeaseStatusPastDuePeriod
P60D
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1600000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1700000 usd
CY2024Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
14783000 usd
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
14757000 usd
CY2024Q1 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
10810000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
10483000 usd
CY2024Q1 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
6360000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
6613000 usd
CY2024Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4906000 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4925000 usd
CY2024Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
947000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
764000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1253000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1436000 usd
CY2024Q1 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
491000 usd
CY2023Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
491000 usd
CY2024Q1 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
27793000 usd
CY2023Q4 cmct Deferred Rent Receivable And Charges Net
DeferredRentReceivableAndChargesNet
28222000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases such estimates on historical experience, information available at the time, and assumptions the Company believes to be reasonable under the circumstances at such time. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Land
Land
175682000 usd
CY2023Q4 us-gaap Land
Land
175715000 usd
CY2024Q1 us-gaap Land Improvements
LandImprovements
5863000 usd
CY2023Q4 us-gaap Land Improvements
LandImprovements
5862000 usd
CY2024Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
633963000 usd
CY2023Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
633299000 usd
CY2024Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
11573000 usd
CY2023Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
11627000 usd
CY2024Q1 us-gaap Tenant Improvements
TenantImprovements
26596000 usd
CY2023Q4 us-gaap Tenant Improvements
TenantImprovements
26460000 usd
CY2024Q1 us-gaap Development In Process
DevelopmentInProcess
16635000 usd
CY2023Q4 us-gaap Development In Process
DevelopmentInProcess
15915000 usd
CY2024Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
870312000 usd
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
868878000 usd
CY2024Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
169694000 usd
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
164116000 usd
CY2024Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
700618000 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
704762000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
5800000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
4800000 usd
CY2024Q1 cmct Number Of Properties Acquired Or Sold
NumberOfPropertiesAcquiredOrSold
0 property
CY2024Q1 cmct Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leases
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeases
0 usd
CY2023Q1 cmct Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Below Market Leases
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBelowMarketLeases
223000 usd
CY2024Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
0 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
283051000 usd
CY2023Q1 cmct Acquired Finite Lived Intangible Liabilities Useful Life
AcquiredFiniteLivedIntangibleLiabilitiesUsefulLife
P5M
CY2024Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
33709000 usd
CY2023Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
33505000 usd
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
56748000 usd
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
57555000 usd
CY2024Q1 cmct Financing Receivables Deferred Capitalized Costs Net
FinancingReceivablesDeferredCapitalizedCostsNet
1125000 usd
CY2023Q4 cmct Financing Receivables Deferred Capitalized Costs Net
FinancingReceivablesDeferredCapitalizedCostsNet
1130000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1644000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1680000 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
56229000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
57005000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1680000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-36000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1644000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1106000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
51000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1940000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-36000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
51000 usd
CY2024Q1 cmct Financing Receivables Deferred Capitalized Costs Net
FinancingReceivablesDeferredCapitalizedCostsNet
1125000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1644000 usd
CY2024Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
402000 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
56229000 usd
CY2024Q1 cmct Financing Receivables Weighted Average Risk Rating
FinancingReceivablesWeightedAverageRiskRating
1.4
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3852000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3948000 usd
CY2024Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
0 usd
CY2023Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
9000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
471561000 usd
CY2024Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
5000000 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
4175000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
427000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
472813000 usd
CY2024Q1 cmct Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable
LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable
1600000 usd
CY2023Q4 cmct Line Of Credit Facility Accrued Interest And Unused Commitment Fee Payable
LineOfCreditFacilityAccruedInterestAndUnusedCommitmentFeePayable
1800000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
75138000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
255340000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
105780000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11093000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
204000 usd
CY2024Q1 cmct Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
28671000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
476226000 usd
CY2023 cmct Number Of Mortgage Loans Assumed
NumberOfMortgageLoansAssumed
2 mortgage_loan
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22707000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12295000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12715000 usd
CY2024Q1 cmct Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends
DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends
0 usd
CY2023Q1 cmct Dilutive Securities Effect On Basic Earnings Per Share Redeemable Preferred Stock Dividends
DilutiveSecuritiesEffectOnBasicEarningsPerShareRedeemablePreferredStockDividends
0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12295000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12715000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22738000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22707000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22738000 shares
CY2024Q1 cmct Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs
PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts
10900000 usd
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.25 shares
CY2024Q1 cmct Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs
PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts
10900000 usd
CY2024Q1 cmct Preferred Stock And Warrants Offering Costs Non Issuance Specific Costs
PreferredStockAndWarrantsOfferingCostsNonIssuanceSpecificCosts
10900000 usd
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.25 shares
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
662462 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4700000 usd
CY2022Q1 us-gaap Incentive Fee Expense
IncentiveFeeExpense
0 usd
CY2024Q1 cmct Outstanding Loan Commitments And Approvals To Fund Loans
OutstandingLoanCommitmentsAndApprovalsToFundLoans
8200000 usd
CY2024Q1 cmct Tenant Improvements Obligations
TenantImprovementsObligations
4400000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
43229000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
33584000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
24525000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
16843000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
12910000 usd
CY2024Q1 cmct Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
38066000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
169157000 usd
CY2023Q1 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
3 property
CY2024Q1 cmct Number Of Types Of Commercial Real Estate Properties
NumberOfTypesOfCommercialRealEstateProperties
3 property
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3635000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7320000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
270000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
256000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-3905000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-7576000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-175000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-625000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3730000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6951000 usd
CY2024Q1 us-gaap Assets
Assets
887503000 usd
CY2023Q4 us-gaap Assets
Assets
891200000 usd
CY2024Q1 cmct Capital Expenditures
CapitalExpenditures
13540000 usd
CY2023Q1 cmct Capital Expenditures
CapitalExpenditures
9112000 usd
CY2024Q1 cmct Disposal Group Including Discontinued Operation New Mortgage Loans
DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans
7733000 usd
CY2023Q1 cmct Disposal Group Including Discontinued Operation New Mortgage Loans
DisposalGroupIncludingDiscontinuedOperationNewMortgageLoans
10781000 usd
CY2024Q1 cmct Capital Expenditures And Disposal Group Originations Cost
CapitalExpendituresAndDisposalGroupOriginationsCost
21273000 usd
CY2023Q1 cmct Capital Expenditures And Disposal Group Originations Cost
CapitalExpendituresAndDisposalGroupOriginationsCost
19893000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000908311-24-000019-index-headers.html Edgar Link pending
0000908311-24-000019-index.html Edgar Link pending
0000908311-24-000019.txt Edgar Link pending
0000908311-24-000019-xbrl.zip Edgar Link pending
cmct-20240331.htm Edgar Link pending
cmct-20240331.xsd Edgar Link pending
exhibit103jpmorgan-cmctxci.htm Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cmct-20240331_lab.xml Edgar Link unprocessable
cmct-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cmct-20240331_cal.xml Edgar Link unprocessable
cmct-20240331_def.xml Edgar Link unprocessable
cmct-20240331_htm.xml Edgar Link completed